None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Male or female participants aged 19 years or older 2) Individuals with confirmed chronic tinnitus lasting for more than 3 months 3) Individuals with pure-tone air conduction hearing thresholds of 60 dB HL or lower (based on the 6-division method) 4) Individuals with a Tinnitus Handicap Inventory (THI) score of 18 or higher 5) Individuals capable of using the internet and mobile applications 6) Individuals who have understood the nature of the clinical trial and voluntarily signed the informed consent form
Exclusion criteria
Exclusion criteria: 1) Individuals diagnosed with objective tinnitus (e.g., pulsatile or muscular tinnitus) 2) Individuals whose tinnitus is confirmed to be caused by middle ear infection, inner ear infection, or Eustachian tube disorder 3) Individuals diagnosed with any other primary neurodegenerative dementia, schizophrenia, or bipolar disorder, or any other DSM-V Axis I disorder, excluding depression 4) Individuals deemed unsuitable for participation in this clinical trial by the principal investigator 5) Individuals currently participating in another clinical trial or who have participated in another clinical trial within one month prior to the screening date
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total Tinnitus Handicap Inventory score change | — |
Secondary
| Measure | Time frame |
|---|---|
| Total Tinnitus Functional Index score change;Change in tinnitus pitch and loudness matching;Change in Visual analog scale (Emotional Distress);Change in Visual analog scale (Cognitive Distress);Satisfaction questionnaire score | — |
Countries
Korea, Republic of
Contacts
The Catholic University of Korea, Seoul St. Mary's Hospital